Upgrade to SI Premium - Free Trial

Roivant Sciences (ROIV) PT Raised to $35 at BofA Securities

July 31, 2026 5:13 AM
BofA Securities analyst Chi Fong raised the price target on Roivant Sciences (NASDAQ: ROIV) to $35.00 (from $31.50) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change